2,3,4,6-tetrachlorophenol has been researched along with Cerebral Ischemia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, SY; Choi, JS; Chung, JM; Gwag, BJ; Joo, CK; Oh, S; Ryoo, IJ; Seo, SY; Yoo, ID; Yun, BS | 1 |
1 other study(ies) available for 2,3,4,6-tetrachlorophenol and Cerebral Ischemia
Article | Year |
---|---|
Complestatin is a noncompetitive peptide antagonist of N-methyl-D-aspartate and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid/kainate receptors: secure blockade of ischemic neuronal death.
Topics: Animals; Apoptosis; Brain Ischemia; Calcium; Cell Death; Chlorophenols; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Glucose; Kainic Acid; Mice; Neurons; Neuroprotective Agents; Oligopeptides; Oxidative Stress; Oxygen; Patch-Clamp Techniques; Peptides, Cyclic; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Retinal Vessels | 2001 |